Opening book details…
About this Medicine article
Updated follow-up analysis in the REP 401 protocol: Treatment HBeAg negative chronic hepatitis B infection with REP 2139 or REP 2165, tenofovir disoproxil fumarate and pegylated interferon alfa-2a by Vaillant, A.; Bazinet, M.; Pantea, V.; Placinta, G.; Moscalu, I.; Cebotarescu, V.; Cojuhari, L.; Jimbei, P.; Iarovoi, L.; Smesnoi, V.; Musteata, T.; Jucov, A.; Krawczyk, A. is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Vaillant, A.; Bazinet, M.; Pantea, V.; Placinta, G.; Moscalu, I.; Cebotarescu, V.; Cojuhari, L.; Jimbei, P.; Iarovoi, L.; Smesnoi, V.; Musteata, T.; Jucov, A.; Krawczyk, A.
- Publisher
- Elsevier Science; Elsevier ; Elsevier BV; Wiley (ISSN 0168-8278)
- Published
- 2018
- Field
- Medicine (Health Sciences)